SoHo Capital

Soho Global Health is a leading Indonesian healthcare company specializing in natural medicines, consumer health products, and prescription pharmaceuticals. Founded in 1946, the company has established itself as a pioneer in evidence-based herbal medicine, with flagship brands such as Imboost and Curcuma Plus dominating the local market. Beyond manufacturing, Soho Global Health operates an extensive nationwide distribution network through its subsidiary, Parit Padang Global, serving as a key partner for international pharmaceutical firms entering the Indonesian market. The company is publicly traded on the Indonesia Stock Exchange and continues to focus on expanding its portfolio of wellness and therapeutic products across Southeast Asia. Its commitment to research and development in natural products distinguishes it within the regional pharmaceutical landscape.